Abstract
Because it was difficult to explain the diverse effects of centrally acting drugs on the basis of the single neurohumoral agent acetylcholine (ACh), Brodie and Shore [1, 2] proposed in an interesting hypothesis that 5-hydroxytryptamine (serotonin or 5-HT) and norepinephrine might act as the main neurohumors of the trophotropic and ergotropic systems in brain. Much of the recent data from Brodie’s laboratories have been explained in terms of this theory [3–6]. The theory was based on the concepts of Hess [7, 8], namely, that there is a functional integration of the autonomic nervous system with the rest of the brain and that a subcortical system exists which consists of separate and antagonistic divisions, the ergotrophic and trophotropic. These ideas completely omit from discussion any reference to the ACh-cholinesterase (ChE) system. Data in the literature suggest that ACh is an important link in the chain of biochemical events associated with excitation of brain neurons, and in the author’s opinion ACh should be included in any theory of neurohumoral action [9–11]. Furthermore, the criteria necessary for a neurohumoral classification as used for serotonin and norepinephrine—such as (1) stored in an inactive form, (2) easily changed to a free or active form, (3) localized in different parts of the brain at varying concentration levels, (4) an enzyme present for its synthesis, and (5) an enzyme present for its destruction—apply equally well for ACh. In addition, when one compares the activities of cholinesterase and monoamine oxidase (MAO), the enzymes which keep ACh and 5-HT at physiological levels, it is interesting that in the brain the ratio is approximately 100 in favor of ChE activity, whereas in the peripheral organs, such as the liver, it is a small fraction of this value [12, 13]. Even if one suggests that ChE is normally present in great excess, a comparison of ACh content with 5-HT in the brain of some species from which data is available indicates that the former is present in amounts about ten times higher [see ref. 14, 15 for comparison in the rat, ref. 16 for rabbit midbrain]. Such data, taken together with the other facts, suggested to the author that ACh rather than 5-HT could be the more important neurohumoral agent in brain. If a trophotropic division exists in brain, then ACh could take the role suggested originally for 5-HT. One would then be left to explain the role of serotonin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brodie, B. B., and Shore, P. A.: Unified concept of interaction of psycho-tropic agents with neurohormones, Fed. Proc. 17: 353, 1958.
Brodie, B. B., Spector, S., and Shore, P. A.: Interaction of drugs with norepinephrine in the brain, Symposium on Catecholamines, Williams & Wilkins Company, Baltimore, 1959, p. 548.
Brodie, B. B., Bogdanski, D. F., and Shore, P. A.: The action of psychotropic drugs. A biochemical and physiological interpretation, in Rinkel, M., and Denber, H. C. B., Eds.: Chemical Concepts of Psychosis, McDowell and Obolensky, Inc., New York 1958, p. 190.
Shore, P. A., and Brodie, B. B.: Influence of various drugs on serotonin and norepinephrine in the brain, in Garattini, S., and Ghetti, V., Eds.: Psychotropic Drugs, Elsevier, Amsterdam, 1957, p. 423.
Brodie, B. B., and Shore, P. A.: On a role for serotonin and norepinephrine as chemical mediators in the central autonomic nervous system. in Hoagland, H., Ed.: Hormones, Brain Function and Behavior, Academic Press, Inc., New York, 1957, pp. 161–176.
Kuntzman, R., Costa, E„ Gessa, G. L., Hirsch, C., and Brodie, B. B.: Corn-bined use of a-Methyl meta-tyrosine and reserpine to associate norepinephrine with excitation and serotonin with sedation, Fed. Proc. 20: 308, 1961.
Hess, W. R.: Das Zwischenhirn, Syndrome, Localisationen, Funktionen, 2nd ed., Benno Schwabe, Basle, 1954.
Hess, W. R.: Diencephalon, Autonomic and Extrapyramidal Functions, Monog. Biol. Med., Vol. III, Grune & Stratton, Inc., New York, 1954.
Aprison, M. H.: Rate of compulsive circling in relation to accumulation of cerebral acetylcholine, J. Neurochem, 2: 197, 1958.
Nachmansohn, D.: Chemical and Molecular Basis of Nerve Activity, Academic Press, Inc., New York, 1959.
Rinaldi, F., and Himwich, H. E.: Alerting responses and actions of atropine and cholinergic drugs, A.M.A. Arch. Neurol. Psychiat. 73: 387, 1955.
Aprison, M. H., Folkerth, T. L., and Hanson, K. M.: Cholinesterase/monoamine oxidase ratios in the avian central nervous system, Physiologist 3: 10, 1960.
Davison, A. N.: Physiological role of monoamine oxidase, Physiol. Rev. 38: 729, 1958.
Twarog, B. M., and Page, L H.: Serotonin content of some mammalian tissues and urine and a method for its determination, Am. J. Physiol. 175: 157, 1953.
Crossland, J., Pappius, H.M., and Elliott, K. A. C.: Acetylcholine content of frozen brain, ibid. 183: 27, 1955.
Aprison, M. H., and Wolf, M. A.: Unpublished data.
Gordon, P., Haddy, F. J., and Lipton, M. A.: Serotonin antagonism of noradrenaline in vivo, Science 128: 531, 1958.
Aprison, M. H., and Folkerth, T. L.: Comparison of Monoamine Oxidase and Cholinesterase Activities in Several Discrete Areas from Pigeon Brain, to be published.
Aprison, M. H., and Nathan, P.: Determination of acetylcholine in small samples of fresh brain tissue, Arch. Biochem. Biophys, 66: 388, 1957.
Dixon, M., and Webb, E. C.: Enzymes, Academic Press, Inc., New York, 1958.
Krupka, R. M., and Laidler, K. J.: Molecular mechanisms for hydrolytic enzyme action. I. Apparent noncompetitive inhibition, with special reference to acetylcholinesterase, J. Am. Chem. Soc. 83: 1445, 1961.
Aprison, M. H., Nathan, P., and Himwich, H. E.: Cholinergic mechanism of brain involved in compulsive circling, Am. J. Physiol. 184: 244, 1956.
Aprison, M. H., and Nathan, P.: Acetylcholine concentrations in the brain of rabbits exhibiting forced turning movements, ibid. 189: 389, 1957.
Aprison, M. H. Effect of 5-hydroxytryptamine on cholinesterase activity, Fed. Proc. 19: 275, 1960.
Woolley, D. W.: A probable mechanism of action of serotonin, Proc. Nat. Acad. Sci. U.S. 44: 197, 1958.
Wilson, I. B., and Cohen, M.: The essentiality of acetylcholinesterase in conduction, Biochim. Biophys, Acta 11: 147, 1953.
Costa, E., Gessa, G. L., Hirsch, C., and Kuntzman, R.: On current status of serotonin as brain neurohormone and in action of reserpine-like drugs (Abstr., New York Academy of Science Conference on Some Biological Aspects of Schizophrenic Behavior, New York, April 6–8, 1961.
Friess, S. L., and McCarville, W. J.: Nature of the acetyl-cholinesterase surface. I. Some potent competitive inhibitors of the enzyme, J. Am. Chem. Soc. 76: 1363, 1954.
Malhotra, C. L., and Pundlik, P. G.: The effect of reserpine on the acetyl-choline content of different areas of the central nervous system of the dog, Brit. J. Pharmacol. 14: 46, 1959.
Pepeu, G. L., and Giarman, N. J.: The effect of certain neuropharmacologic agents on brain acetylcholine, Fed. Proc. 19: 280, 1960.
Canal, N., and Maffei-Facciolo, A.: Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor, J. Neurochem. 5: 99, 1959.
Aprison, M. H., Wolf, M. A., Poulos, G. T., and Folkerth, T. L.: Neurochemical correlates of behavior. III. Variation of serotonin levels in several brain parts and other organs during the complete period of maximum behavioral effect after 5-hydroxytryptophan administration, to be published.
Aprison, M. H., and Ferster, C. B.: Neurochemical correlates of behavior. I. Quantitative measurements of the behavioral effects of the serotonin precursor, 5-hydroxytryptophan, J. Pharmacol. Exp. Therap. 131: 100, 1961.
Aprison, M. H., and Ferster, C. B.: Neurochemical correlates of behavior. II. Correlation of brain monoamine oxidase activity with behavioral changes after iproniazid and 5-hydroxytryptophan administration, J. Neurochem. 6: 350, 1961.
Paasonen, M. K., and Dews, P. B.: Effects of Raunescine and Isoraunescine on behavior and on the 5-hydroxytryptamine and noradrenalin contents of brain, Brit. J. Pharmacol. 13: 84, 1958.
Brodie, B. B., and Shore, P. A.: A concept for a role of serotonin and nor-epinephrine as chemical mediators in the brain, Ann. N.Y. Acad. Sci. 66: 631, 1957.
Shore, P. A., and Brodie, B. B.: LSD-like effects elicited by reserpine in rabbits pretreated with iproniazid, Proc. Soc. Exp. Biol. Med. 94: 433, 1957.
Besendorf, H., and Pletscher, A.: Beeinflussung Zentrale Wirkungen von Reserpin und 5- Hydroxytryptamin durch Isonicotinsäurehydrazide, Helv. Physiol. Pharmacol. Acta. 14: 383, 1956.
Stein, L., and Ray, O. S.: Accelerated recovery from reserpine depression by monoamine oxidase inhibitors, Nature 188: 1199, 1960.
Spector, S., Shore, P. A., and Brodie, B. B.: Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835), J. Pharmacol. Exp. Therap. 128: 15, 1960.
Gertner, S.: The effects of monoamine oxidase inhibitors on ganglionic transmission, ibid. 131: 223, 1961.
Gertner, S. B., Paasonen, M. K., and Giarman, N. J.: Presence of 5-hydroxytryptamine in perfusate from sympathic ganglia, Fed. Proc. 16: 1281, 1957.
Gertner, S. B., Paasonen, M. K., and Giarman, N. J.: Studies concerning the presence of 5-hydroxytryptamine (serotonin) in the perfusate from the superior cervical ganglion, J. Pharmacol. Exp. Therap. 127: 268, 1959.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1962 Plenum Press Inc.
About this chapter
Cite this chapter
Aprison, M.H. (1962). On a Proposed Theory for the Mechanism of Action of Serotonin in Brain. In: Wortis, J. (eds) Recent Advances in Biological Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8306-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8306-2_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8308-6
Online ISBN: 978-1-4684-8306-2
eBook Packages: Springer Book Archive